ROYAL BANK OF CANADA - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$4,000
+300.0%
1,930
+589.3%
0.00%
Q2 2023$1,000
-80.0%
280
-85.3%
0.00%
Q1 2023$5,000
-70.6%
1,903
-63.8%
0.00%
Q4 2022$17,000
+70.0%
5,257
+48.5%
0.00%
Q3 2022$10,000
+400.0%
3,540
+621.0%
0.00%
Q2 2022$2,000
-98.6%
491
-95.4%
0.00%
Q1 2022$143,000
-56.9%
10,617
-58.3%
0.00%
Q4 2021$332,000
-65.1%
25,462
-74.9%
0.00%
Q3 2021$952,000
-39.9%
101,513
-34.4%
0.00%
Q2 2021$1,585,000
-34.7%
154,739
+17.2%
0.00%
-100.0%
Q1 2021$2,429,000
-8.8%
131,995
+69.8%
0.00%0.0%
Q4 2020$2,663,000
+424.2%
77,747
+182.7%
0.00%
Q3 2020$508,00027,5000.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$31,126,0003.38%
ACUTA CAPITAL PARTNERS, LLC 400,000$7,360,0002.65%
Logos Global Management LP 1,010,812$18,599,0001.82%
S Squared Technology, LLC 181,220$3,334,0001.58%
Avidity Partners Management LP 1,677,845$30,872,0000.85%
Perceptive Advisors 3,425,916$63,037,0000.80%
RTW INVESTMENTS, LP 2,652,553$48,807,0000.76%
Sofinnova Investments, Inc. 509,168$9,369,0000.56%
HighVista Strategies LLC 32,062$590,0000.44%
DAFNA Capital Management LLC 91,531$1,684,0000.40%
View complete list of ATHIRA PHARMA INC shareholders